959778-25-7

Upstream product

• 1211589-24-0 methyl 4-amino-2-ethyl-benzoate 
• 1283128-54-0 ethyl 4-amino-2-ethyl-benzoate 
• 393-52-2 2-Fluorobenzoyl chloride 
• 3558-19-8 methyl 2-amino-4-nitrobenzoate 
• 619-17-0 4-Nitroanthranilic acid 
• 100959-22-6 methyl 2-bromo-4-nitrobenzoate 
• 959778-15-5 methyl 4-nitro-2-vinyl-benzoate 

Downstream Products

• 959778-40-6 2-ethyl-4-{[(2-fluorophenyl)carbonyl]amino}benzoic acid 
• 959778-42-8 N-[3-ethyl-4-(hydrazinocarbonyl)phenyl]-2-fluorobenzamide 

Relevant academic research and scientific papers

NEW FYN KINASE INHIBITORS

The invention relates to new selective FYN kinase inhibitors of Formula (I), pharmaceutical compositions containing them, and their use for the pharmacological treatment of pain and arthritis, including osteoarthritis and rheumatoid arthritis.

2-PHENYL-5-AMINO-1,3,4-OXADIAZOLES AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel oxadiazole derivatives of formula (1) having pharmacological activity, processes for their preparation, compositions containing them and their use in the treatment of neurological, psychiatric disorders and gastrointestinal disorders through modulation of the nicotinic α7 receptor formula (I).